Coloplast A/S (CLPBY)
6.10
+0.19
(+3.21%)
USD |
OTCM |
Jun 09, 16:00
Coloplast Debt to Equity Ratio : 1.886 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.886 |
| December 31, 2025 | 1.818 |
| September 30, 2025 | 1.404 |
| June 30, 2025 | 1.472 |
| March 31, 2025 | 1.432 |
| December 31, 2024 | 1.278 |
| September 30, 2024 | 1.261 |
| June 30, 2024 | 1.182 |
| March 31, 2024 | 1.513 |
| December 31, 2023 | 1.430 |
| September 30, 2023 | 1.131 |
| June 30, 2023 | 3.408 |
| March 31, 2023 | 3.078 |
| December 31, 2022 | 3.758 |
| September 30, 2022 | 2.256 |
| June 30, 2022 | 2.831 |
| March 31, 2022 | 2.899 |
| December 31, 2021 | 0.7845 |
| September 30, 2021 | 0.3411 |
| June 30, 2021 | 0.618 |
| March 31, 2021 | 0.5947 |
| December 31, 2020 | 0.8085 |
| September 30, 2020 | 0.2359 |
| June 30, 2020 | 0.4796 |
| March 31, 2020 | 0.4812 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.6557 |
| September 30, 2019 | 0.1747 |
| June 30, 2019 | 0.4937 |
| March 31, 2019 | 0.4341 |
| December 31, 2018 | 0.6042 |
| September 30, 2018 | 0.2121 |
| June 30, 2018 | 0.5905 |
| March 31, 2018 | 0.6109 |
| December 31, 2017 | 0.6355 |
| September 30, 2017 | 0.2446 |
| June 30, 2017 | 0.5137 |
| March 31, 2017 | 0.5257 |
| December 31, 2016 | 0.6834 |
| September 30, 2016 | 0.0438 |
| June 30, 2016 | 0.2052 |
| March 31, 2016 | 0.0051 |
| December 31, 2015 | 0.0971 |
| September 30, 2015 | 0.0212 |
| June 30, 2015 | 0.1345 |
| March 31, 2015 | 0.0721 |
| December 31, 2014 | 0.068 |
| September 30, 2014 | 0.0146 |
| June 30, 2014 | 0.0284 |
| March 31, 2014 | 0.0222 |
| December 31, 2013 | 0.0212 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ambu A/S | 0.0903 |
| Abbott Laboratories | 0.654 |
| AngioDynamics, Inc. | 0.0657 |
| Alphatec Holdings, Inc. | 33.03 |
| AtriCure, Inc. | 0.1524 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.193B |
| Total Liabilities (Quarterly) | 5.213B |
| Shareholders Equity (Quarterly) | 1.980B |
| Current Ratio | 1.748 |
| Net Debt Paydown Yield | -1.28% |